We're raising our price target on Salesforce after results defy 'SaaSpocalypse'

Salesforce shares surged ~12% in extended trading after fiscal Q2 results beat expectations: revenue of $11.35B vs $11.32B consensus (+9.9% YoY) and adjusted EPS of $5.90. The company also guided Q3 revenue to $11.42B–$11.5B (above the $11.41B LSEG consensus) and raised confidence in second-half acceleration with constant-currency growth of 11%–12% and adjusted EPS of $3.42–$3.44 vs $3.37 consensus. Salesforce highlighted accelerating AI-related metrics—Agentforce ARR rising to $1.5B in the quarter (up from $1.2B in Q1)—and announced a new Claude integration with Anthropic (Claudeforce), reinforcing its stance that AI will augment rather than replace its CRM platform.

Analysis

This is a near-term multiple event for enterprise software, not just a quarter beat. The market has been pricing a binary AI threat to seat-based SaaS; CRM’s setup argues the more durable framework is a bifurcation between vendors that own workflow data and distribution, and those that are thin UI layers. That should relieve some pressure on the broader software complex over the next 1-3 months, but it also raises the bar for names that cannot show the same “AI attached to proprietary data” advantage.

Second-order, the bigger loser is not CRM itself but the category of software exposed to direct substitution or commoditization by model-layer tools. INTU remains a cleaner short on that theme than other large-cap software names because the substitution risk is more visible and the customer is more price-sensitive; if buyers can credibly swap into cheaper AI-native alternatives, multiple compression can happen before revenue damage shows up. WDAY is less vulnerable than INTU but still has to prove its workflow moat is deeper than a feature set; if CRM gets rewarded for AI integration, investors will demand the same proof elsewhere.

The key falsifier is not next-day price action, but whether CRM can sustain cRPO/renewal improvement and convert AI attach into incremental net revenue over the next two quarters. Dreamforce is the obvious catalyst window; if the product story does not translate into measurable pipeline or higher average deal sizes, the stock can give back a large part of the gap. Contrarianly, the market may be overestimating how quickly AI can replace enterprise systems of record: the real monetization path may be slower than the narrative, so the initial re-rating could be right on sentiment but early on fundamentals.

Key Decisions for Investors

• Buy CRM on a 3%-5% post-gap pullback over the next 1-2 weeks; target a 10%-15% rerating if Dreamforce converts the product story into measurable pipeline, with a stop if next quarter cRPO growth slips back below the low-teens.
• Relative-value: long CRM / short INTU for 1-3 months as a hedge against AI-substitution risk; CRM has the stronger data moat while INTU is more exposed to cheaper AI-native alternatives and sentiment can reprice faster than earnings.
• Avoid chasing the open in the software basket; wait for the first fade and then add only if CRM holds the gap into the first 3-5 sessions, which would indicate institutional rather than retail-driven demand.
• If CRM trades above the prior highs without a corresponding Dreamforce pipeline update, take partial profits; the move is likely to outrun fundamental proof until the next earnings cycle.